Highlights By reviewing 120 Target Product Profiles (TPPs), this study identified key aspects of TPP development processes, stakeholder involvement, common themes, major limitations, and priorities for follow-up research. Health technologies were classified into five categories, and the pr

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le

Living longer is inevitable. Living better requires policy choices. Happy ageing is achieved through policy impact, not policy volume. ASEAN does not lack ageing policies — it lacks evidence on what works. While many Member States have introduced national plans, pensions, and health programme

Tuberculosis is caused by bacterium called Mycobacterium tuberculosis. It is a significant problem in Thailand as seen that in 2021 Thailand is in the World Health Organization’s list of 30 high-burden countries for tuberculosis. One of the problems about tuberculosis is inaccurate diagnosis due to insufficient sensitivity and specificity of prim

The development of health and medical innovation is a key national strategy for Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a high-value medical and wellness hub while reducing dependence on imported medical technologies. The Thai Innovation List was established to promote the commerc

This project evaluates Thailand’s maternal acellular pertussis vaccination policy after its inclusion in the Universal Health Coverage benefit package. Although the vaccine is available free of charge, uptake among pregnant women remained low in 2024. The study combines health economic modelling, budget impact analysis, and quantitative and quali

Background Target Product Profiles (TPPs) serve as strategic tools for planning medical innovation development, facilitating communication with regulators, and developing market access strategies. Modelling can assist TPPs development and provide guidance on defining attributes. This scoping review

The development of medical innovation is one of Thailand’s key strategic priorities, as outlined in the 13th National Economic and Social Development Plan (2023–2027), with Milestone 4 positioning Thailand as a hub for high-value medical and healthcare services. However, Thailand’s research and development in medical technologies and health i

The project aims to evaluate the cost-effectiveness, economic impact, and feasibility of integrating this herbal innovation into Thailand’s healthcare system. By applying Early HTA techniques, this study will provide insights for decision-makers, improve resource allocation, and support future investments in innovative medical solutions.67301075M

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr